MEDICINES CONTROL COUNCIL

Similar documents
MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

MEDICINES CONTROL COUNCIL

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 14 August 2013 No. 5263

MEDICINES CONTROL COUNCIL

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 February 2013 No. 5142

Medicines availability short-term supply issues Last updated 01/05/18

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$5.60 WINDHOEK - 31 July 2012 No. 5003

WHO Global Price Reporting Mechanism the importance of data registration for the regulation of antiretrovirals (ARV) and access to treatment

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

Marketing authorisations granted in September 2012

Kern Pharma Portfolio 2014

State of Industry Readiness for the New Demand Following the New Treatment Guidelines

Product List Finished Dosage Forms (FDF) B2B Business

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

Recommended Comparator Products: Medicines for HIV/AIDS and Related Diseases

Supplier/ Manufacturer(s) Unit III, Survey No 51, Plot No IDA, Jeedimetla, Hyderabad, Telangana, Hetero labs limited

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015

NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,

Recommended comparator products: Medicines for HIV/AIDS and related diseases

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet

Information for Vermont Prescribers of Prescription Drugs

Approved by TAC Order to be given within 1 month-date

Information for Vermont Prescribers of Prescription Drugs

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

MICROMEDEX(R) Healthcare Series Integrated Index

Thank you for your request for information that has been processed under reference number

Information for Vermont Prescribers of Prescription Drugs

TLS HEALTH Product list up-dated 2017 (Origin: Portugal)

YES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 A NO BENEFIT SANDOZ AMITRIPTYLINE 25

2017 Formulary Changes Year to Date

Free Trial Future Generics Database

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

Advance Notification of Amendments to the March 2017 Drug Tariff

Price Changes advised by Pharmac As at 12 June 2015

NB Drug Plans Formulary Update

TABLETS & CAPSULES. 8 Artemether + Lumafentarine Tablet (24 Tablet ) and Candesartan Tablet 8mg,16mg and 32 mg

Innovative Products Available. OTC Products Available

Ontario Drug Benefit Formulary/Comparative Drug Index

Barr Laboratories, Inc. et al.; Withdrawal of Approval of 68 Abbreviated New Drug Applications

YES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 A NO BENEFIT SANDOZ AMITRIPTYLINE 25

DT Description Price Category Price change

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Each hard gela n capsule contains: Acebrophylline 100 mg. Each film coated tablet contains Aceclofenac IP 100 mg

BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

Monographs on ARV and hepatitis medicines in The International Pharmacopoeia

Updates to the Alberta Drug Benefit List. Effective July 1, 2018

Advance Notification of Amendments to the August 2018 Drug Tariff

LIST OF DRUGS DURING 2004

Antiretroviral Dosing in Renal Impairment

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

Updates to the Alberta Drug Benefit List. Effective December 1, 2018

HIV Infection & AIDS in Low- and Middle-Income Countries

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

Clinical Study Report Synopsis

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Update on progress of MPP sublicensees


1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017

Updates to the Alberta Drug Benefit List. Effective September 1, 2018

Oncology supportive medicine list (formulary) 2016

Chapter 5 ~ Infections

MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS

A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database

Response to Day - 75 Comments:PT/H/0403/ /E/ P DRUG PRODUCT ESCITALOPRAM TABLETS

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

List of changes in Out-Patients Formulary

Information for Vermont Prescribers of Prescription Drugs DUZALLO (lesinurad and allopurinol) Tablets

List of Products Approved By Drugs Control Organization, Jaipur Sr. No. Name of Product Tablets Biological

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs

PRAC recommendations on signals

The Medicines Patent Pool: An Update. June 2012 Geneva, Switzerland

PBS PRICE INCREASES - AUGUST 2014 SCHEDULE

Antiretroviral Pregnancy Registry

Updates to the Alberta Drug Benefit List. Effective February 1, 2018

Transcription:

MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605 A39/34/0606 A39/34/0607 A39/34/0608 AFRICA AFRICA AFRICA AFRICA 41/11.10/0215 RECKITT BENCKISER METACAM 20 mg/ml FOR CATTLE, PIGS AND HORSES NICOTINELL FRUIT 2 mg COATED CHEWING GUM NICOTINELL FRUIT 4 mg COATED CHEWING GUM NICOTINELL MINT 2 mg COATED CHEWING GUM NICOTINELL MINT 4 mg COATED CHEWING GUM GAVISCON LIQUISHOT 41/21.10/0523 SERONO SA OVITRELLE 250 µg/0,5 ml 42/26/0608 PHARMACARE LIMITED ASPEN CARBOPLATIN 50 mg 42/26/0609 PHARMACARE LIMITED ASPEN CARBOPLATIN 150 mg 42/26/0610 PHARMACARE LIMITED ASPEN CARBOPLATIN 450 mg 42/20.1.1/0247 PHARMACARE LIMITED ASPEN AZITHROMYCIN IV Each 1,0 ml solution contains: MELOXICAM 20,0 mg NICOTINE 2,0 mg NICOTINE 4,0 mg NICOTINE 2,0 mg NICOTINE 4,0 mg Each sachet contains: SODIUM ALGINATE 500,0 mg Each 0,5 ml solution contains: CHORIOGONADOTROPIN ALFA 250,0 µg Each 5,0 ml vial contains: CARBOPLATIN 50,0 mg Each 15,0 ml vial contains: CARBOPLATIN 150,0 mg Each 45,0 ml vial contains: CARBOPLATIN 450,0 mg AZITHROMYCIN MONOHYDRATE AZITHROMYCIN 500,0 mg 12.64_Notification_of Apr12_v1.docx June 2012 Page 1 of 5

42/21.5.1/0310 XIXIA 42/21.5.1/0311 XIXIA 42/21.5.1/0312 XIXIA PREDNISOLONE 120 PREDNISOLONE 500 PREDNISOLONE 1 000 HEMISUCCINATE 120,0 mg HEMISUCCINATE 500,0 mg HEMISUCCINATE 1 000,0 mg 42/7.1.3/0352 PHARMACARE LIMITED TRANDOPRESS 0,5 mg Each capsule contains: TRANDOLAPRIL 0,5 mg 42/20.1.1/0641 GULF DRUG COMPANY GULF CEFOTAXIME 2 g CEFOTAXIME SODIUM CEFOTAXIME 2,0 g 42/7.5/0805 PHARMACARE LIMITED VATICOL XL FLUVASTATIN SODIUM FLUVASTATIN 80,0 mg 42/7.1.3/0947 RANBAXY SA IRBELO 75 IRBESARTAN 75,0 mg 42/7.1.3/0948 RANBAXY SA IRBELO 150 IRBESARTAN 150,0 mg 42/7.1.3/0949 RANBAXY SA IRBELO 300 IRBESARTAN 300,0 mg 42/7.1.3/0950 RANBAXY SA RAN IRBESARTAN 75 IRBESARTAN 75,0 mg 42/7.1.3/0951 RANBAXY SA RAN IRBESARTAN 150 IRBESARTAN 150,0 mg 42/7.1.3/0952 RANBAXY SA RAN IRBESARTAN 300 IRBESARTAN 300,0 mg 42/26/0965 XIXIA 42/26/0966 XIXIA MYLAN CARBOPLATIN 150 MYLAN CARBOPLATIN 450 CARBOPLATIN 150,0 mg CARBOPLATIN 450,0 mg 42/2.9/0967 PHARMACARE LIMITED TRAMASPEN 50 mg Each capsule contains: 42/21.12/1096 ASTRAZENECA 43/2.6.5/0039 TRINITY PHARMA (PTY) 43/2.6.5/0040 TRINITY PHARMA (PTY) EVERDEX 1 mg RISPEVON 1 RISPEVON 2 TRAMADOL HYDROCHLORIDE 50,0 mg ANASTROZOLE 1,0 mg RISPERIDONE 1,0 mg RISPERIDONE 2,0 mg 12.64_Notification_of Apr12_v1.docx June 2012 Page 2 of 5

43/2.6.5/0041 TRINITY PHARMA (PTY) 43/2.6.5/0042 TRINITY PHARMA (PTY) 43/26/0046 XIXIA 43/20.1.1/0062 ORCHID SA 43/20.1.1/0063 ORCHID SA 43/26/0068 XIXIA 43/20.1.1/0221 BRIMPHARM SA (PTY) RISPEVON 3 RISPEVON 4 MYLAN GEMCITABINE 1 g ORCHID CEFUROXIME 250 mg ORCHID CEFUROXIME 500 mg MYLAN GEMCITABINE 200 mg ZEEMIDE 500 mg 43/11.4.3/0545 PHARMACARE LIMITED ASPEN PANTOPRAZOLE 20 43/11.4.3/0546 PHARMACARE LIMITED ASPEN PANTOPRAZOLE 40 43/20.2.8/0570 AUROBINDO PHARMA 43/20.2.8/0571 AUROBINDO PHARMA 43/2.5/0823 TRINITY PHARMA (PTY) 43/2.5/0824 TRINITY PHARMA (PTY) 43/2.5/0825 TRINITY PHARMA (PTY) 43/2.5/0826 TRINITY PHARMA (PTY) VUDERIT 30 mg VUDERIT 40 mg EPIMATE 25 EPIMATE 50 EPIMATE 100 EPIMATE 200 RISPERIDONE 3,0 mg RISPERIDONE 4,0 mg GEMCITABINE GEMCITABINE 1,0 g CEFUROXIME AXETIL CEFUROXIME 250,0 mg CEFUROXIME AXETIL CEFUROXIME 500,0 mg GEMCITABINE GEMCITABINE 200,0 mg AZITHROMYCIN DIHYDRATE AZITHROMYCIN 500,0 mg SESQUIHYDRATE PANTOPRAZOLE 20,0 mg SESQUIHYDRATE PANTOPRAZOLE 40,0 mg STAVUDINE 30,0 mg STAVUDINE 40,0 mg TOPIRAMATE 25,0 mg TOPIRAMATE 50,0 mg TOPIRAMATE 100,0 mg TOPIRAMATE 200,0 mg 43/11.4.3/1001 NYCOMED PANTOLOC OTC SESQUIHYDRATE PANTOPRAZOLE 20,0 mg 43/1.2/1015 ZYDUS HEALTHCARE SA ZYDUS ESCITALOPRAM 10 mg ESCITALOPRAM OXALATE EQUIVALENT TO ESCITALOPRAM 10,0 mg 12.64_Notification_of Apr12_v1.docx June 2012 Page 3 of 5

43/7.1.3/1044 AUROBINDO PHARMA 43/7.1.3/1045 AUROBINDO PHARMA 43/7.1.3/1046 AUROBINDO PHARMA 43/7.1.3/1047 AUROBINDO PHARMA 44/20.1.1/0316 BIOTECH LABORATORIES (PTY) 44/34/0391 CIPLA MEDPRO (PTY) 44/34/0392 CIPLA MEDPRO (PTY) 44/8.1/0550 NOVO NORDISK (PTY) 44/8.1/0551 NOVO NORDISK (PTY) 44/8.1/0552 NOVO NORDISK (PTY) 44/13.9.1/0632 ADCOCK INGRAM LIMITED BIQURETIC 10/ BIQURETIC 20/ AURO QUINAPRIL CO 10/ AURO QUINAPRIL CO 20/ KANAMYCIN 1 g BIOTECH SOLVENT FOR DOCELEX 20 SOLVENT FOR DOCELEX 80 NOVOSEVEN 1 mg NOVOSEVEN 2 mg NOVOSEVEN 5 mg XAMIOL GEL QUINAPRIL 10,0 mg QUINAPRIL 20,0 mg QUINAPRIL 10,0 mg QUINAPRIL 20,0 mg Each ampoule contains: KANAMYCIN SULPHATE KANAMYCIN 1 000,0 mg ETHANOL 13,0 % m/v ETHANOL 13,0 % m/v (rfviia) 1,0 mg (rfviia) 2,0 mg (rfviia) 5,0 mg Each gram contains: CALCIPOTRIOL HYDRATE CALCIPOTRIOL 50,0 µg BETAMETHASONE DIPROPIONATE BETAMETHASONE 0,5 mg 45/20.2.8/0111 MYLAN RILOVIA 200/50 LOPINAVIR 200,0 mg RITONAVIR 50,0 mg 12.64_Notification_of Apr12_v1.docx June 2012 Page 4 of 5

45/20.2.8/0112 MYLAN TENEMINE TENOFOVIR DISOPROXIL FUMARATE 300,0 mg EMTRICITABINE 200,0 mg 45/20.2.8/0169 MYLAN EFRIN EFAVIRENZ 600,0 mg 45/20.2.8/0336 MYLAN RILOVIA 100/25 LOPINAVIR 100,0 mg RITONAVIR 25,0 mg 45/20.2.8/0538 MACLEODS SA MACLEODS LAMIVUDINE 150 MS MANDISA HELA REGISTRAR OF MEDICINES 12.64_Notification_of Apr12_v1.docx June 2012 Page 5 of 5